The Technical AnalystExchange: NASDAQ Sector: Financial Services Industry: Shell Companies
Phoenix Biotech Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.10% $10.37
America/New_York / 7 feb 2024 @ 09:37
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 36.54 mill |
| EPS: | 0 |
| P/E: | 0 |
| Earnings Date: | Mar 30, 2023 |
| SharesOutstanding: | 3.52 mill |
| Avg Daily Volume: | 0.0001 mill |
| RATING 2024-02-07 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | |
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE -18.15 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE -25.74 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 10.30 - 10.44 ( +/- 0.64%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2021-10-08 | Phoenix Biotech Sponsor, Llc | Sell | 82 875 | Class B Common Stock |
| 2021-10-08 | Phoenix Biotech Sponsor, Llc | Buy | 36 733 | Class A common stock |
| 2021-10-08 | Phoenix Biotech Sponsor, Llc | Buy | 18 366 | Warrants |
| 2021-10-08 | Ehrlich Christopher B | Sell | 82 875 | Class B Common Stock |
| 2021-10-08 | Ehrlich Christopher B | Buy | 36 733 | Class A common stock |
| INSIDER POWER |
|---|
| 0.00 |
| Last 17 transactions |
| Buy: 332 698 | Sell: 5 176 507 |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $10.37 (-0.10% ) |
| Volume | 0.0000 mill |
| Avg. Vol. | 0.0001 mill |
| % of Avg. Vol | 7.22 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For PBAXU
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
PBAXU
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.